Cardiovascular DiseasesNCT04091035
Prevalence and Risk Factors for Common Diseases
An observational study of Cardiovascular Diseases and Fracture, run by Anna Nordström.
Trial summary
By using national databases in Sweden the aim of the present project is to: 1. Investigate if the incidence of our most common diseases, such as fracture and cardiovascular disease, has changed from 1970-2017 2. To investigate whether the risk of death for our most common diseases have changed from 1970-2017. 3. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Cardiovascular Diseases, Fracture, Cancer
- What is being tested?
- To describe the incidence of disease and evaluate risk factors
- How many people
- 1,000,000 participants
- Where
- No sites listed yet
- Study dates
- 1 Nov 2019to 1 Nov 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: Se above
Who may be able to join
- All people living in Sweden that is diagnosed with our most common diseases between 1970-2017.
Who cannot join
- None
Trial locations and contacts
No sites are listed yet.
Anna Nordström contact
About this study
Official title: Prevalence and Risk Factors for Common Diseases in Sweden: A Nationwide Cohort Study
By using national databases in Sweden the aim of the present project is to:
- Investigate if the incidence of our most common diseases, such as fracture and cardiovascular disease, has changed from 1970-2017
- To investigate whether the risk of death for our most common diseases have changed from 1970-2017.
- To investigate the risk of a new episode after suffering from our most common diseases from 1970-2017
- To investigate the risk factors for our most common diseases, and whether these have changed from 1970.
- To investigate how severe disease or death affects the health of a close relative.
Read the detailed description
Please see above on the summary.
- Conditions
- Cardiovascular Diseases, Fracture, Cancer
- Being tested
- To describe the incidence of disease and evaluate risk factors
- Medical subject headings
- Cardiovascular Diseases, Fractures, Bone, Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
To describe the incidence of disease and evaluate risk factorsOther
Se above
What is being measured
The primary outcome is the main question the study is designed to answer.
Incidence of disease
To investigate the incidence of the most common diseases, and whether the incidence has changed.
Measured: 1970-2017
Age at diagnosis of disease
To investigate age at diagnosis of our most common diseases, and whether this has changed.
Measured: 1970-2017
Risk of death or disease in relative
Risk of death or disease in close relative to those diagnosed with severe disease or died.
Measured: 1970-2017
Risk factors for disease or death
Risk factors for our most common diseases or death
Measured: 1970-2017
Secondary outcomes (1)
Risk for readmission
To investigate the risk of readmission for our most common diseases, and whether this risk has changed,
Measured: 1970-2017
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Sep 2019
- Study start1 Nov 2019 (estimated)
- Primary completion1 Nov 2020 (estimated)
- Study completion1 Nov 2020 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cardiovascular DiseasesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 1,000,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Anna Nordström
- Sponsor type
- Other government
- Collaborators
- Umeå University
- Responsible party
- Sponsor-investigator, Anna Nordström, Region Västerbotten
- Investigators
- Peter Nordström, Professor, Study director, Umea University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04091035
- Sponsor's protocol ID
- VasterbottenCounty
- Status last verified
- Sep 2019
- First submitted
- 13 Sep 2019
- Last updated
- 8 Oct 2019
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Oct 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevalence and Risk Factors for Common Diseases in Sweden: A Nationwide Cohort Study
- ClinicalTrials.gov ID
- NCT04091035
- Acronym / sponsor ID
- VasterbottenCounty
- Conditions
- Cardiovascular Diseases, Fracture, Cancer
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 1,000,000 participants (estimated)
- Lead sponsor
- Anna NordströmOther government
- Collaborators
- Umeå University
- Study start
- 1 Nov 2019 (estimated)
- Primary completion
- 1 Nov 2020 (estimated)
- Study completion
- 1 Nov 2020 (estimated)
- First posted
- 16 Sep 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
By using national databases in Sweden the aim of the present project is to:
- Investigate if the incidence of our most common diseases, such as fracture and cardiovascular disease, has changed from 1970-2017
- To investigate whether the risk of death for our most common diseases have changed from 1970-2017.
- To investigate the risk of a new episode after suffering from our most common diseases from 1970-2017
- To investigate the risk factors for our most common diseases, and whether these have changed from 1970.
- To investigate how severe disease or death affects the health of a close relative.
Detailed description
Please see above on the summary.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Se above
Key inclusion criteria (1 listed)
- All people living in Sweden that is diagnosed with our most common diseases between 1970-2017.
Key exclusion criteria (1 listed)
- None
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| To describe the incidence of disease and evaluate risk factorsSe above | Other | – |
Primary outcome
Incidence of disease
Time frame: 1970-2017
To investigate the incidence of the most common diseases, and whether the incidence has changed.
Age at diagnosis of disease
Time frame: 1970-2017
To investigate age at diagnosis of our most common diseases, and whether this has changed.
Risk of death or disease in relative
Time frame: 1970-2017
Risk of death or disease in close relative to those diagnosed with severe disease or died.
Risk factors for disease or death
Time frame: 1970-2017
Risk factors for our most common diseases or death
1 secondary outcome
Risk for readmission
Time frame: 1970-2017
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Oct 2019.
- Individual participant dataSharing planned: No
Related trials for Cardiovascular Diseases
Recruiting
EVERO Drug-coated Balloon (DCB) Randomized Trial
Peripheral Vascular Disease, Peripheral Arterial Disease
Recruiting
Systematic Ambulatory ECG Monitoring Following TAVI
Aortic Stenosis, Conduction Disturbances
Recruiting
Postural Mobilization Compared to Noradrenaline Only in Off-Pump CABG Surgery
Coronary Artery Disease With Need for Bypass Surgery, Coronary Artery Disease(CAD)
Enrolling by invitation
Optical Coherence Tomography in Acute Vessel Evaluation
Ischemic Heart Disease, Ischemic Coronary Artery Disease
Active, not recruiting
Safety and Efficacy Evaluation of the iNstroke 4F Thromboaspiration Catheter in Patients With Acute Ischaemic Stroke Due to Primary Distal Medium Vessel Occlusions (DMVO)
Acute Ischemic Stroke
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Anna Nordström contact
Peter Nordström, Professor study director
Umea University
Questions about this trial
What is this clinical trial studying?
An observational study of Cardiovascular Diseases and Fracture, run by Anna Nordström.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 8 Oct 2019. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Peter Nordström, Professor (+46907851000, peter.nordstrom@umu.se), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Incidence of disease (time frame: 1970-2017). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2019.